Westlake BioPartners Opportunity Fund I, L.P.
CIK: 0001811946
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KYTX
Kyverna Therapeutics, Inc.
10% Owner
Discretionary Trading P&L
Holdings
About Westlake BioPartners Opportunity Fund I, L.P.
Westlake BioPartners Opportunity Fund I, L.P. (SEC CIK 0001811946) files insider reports with the SEC as 10% Owner of Kyverna Therapeutics, Inc. (KYTX).
Signal8 holds 1 ownership filing by Westlake BioPartners Opportunity Fund I, L.P., a Form 4, filed on Dec 22, 2025. Those filings report 1 transaction, the latest on Dec 18, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Westlake BioPartners Opportunity Fund I, L.P.'s filings is in WESTLAKE VILLAGE, CA.
Recent filings by Westlake BioPartners Opportunity Fund I, L.P.
- Dec 18, 2025: Open-market purchase of KYTX shares (Form 4, code P).
Other insiders filing for Kyverna Therapeutics, Inc. (KYTX)
- CLARK IAN T, Director
- Cohen Fred E, Director
- SEIDENBERG BETH C, Director
- Shaw Christi, Executive Chairperson
- Aktar Mert, Director
- Martini Gregory S., Chief Financial Officer